US Patent

US7741356 — Compounds as opioid receptor modulators

Composition of Matter · Assigned to Janssen Pharmaceutica NV · Expires 2029-05-27 · 3y remaining

Vulnerability score 10/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects novel opioid receptor modulators and methods for preparing them, as well as pharmaceutical compositions containing these compounds.

USPTO Abstract

The present invention is directed to novel opioid receptor modulators of Formula (I). The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors.

Drugs covered by this patent

Patent Metadata

Patent number
US7741356
Jurisdiction
US
Classification
Composition of Matter
Expires
2029-05-27
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.